Increased risk of infection with SARS-CoV-2 Omicron compared to Delta in vaccinated and previously infected individuals, the Netherlands, 22 November to 19 December 2021
Dirk Eggink, Stijn P. Andeweg, Harry Vennema, Noortje van Maarseveen, Klaas Vermaas, Boris Vlaemynck, Raf Schepers, Arianne B. van Gageldonk-Lafeber, Susan van den Hof, Chantal B.E.M. Reusken, Mirjam J. Knol
doi: https://doi.org/10.1101/2021.12.20.21268121
Dirk Eggink
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Stijn P. Andeweg
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Harry Vennema
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Noortje van Maarseveen
2Saltro Diagnostic Center for Primary Care, Utrecht, The Netherlands
3Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
Klaas Vermaas
2Saltro Diagnostic Center for Primary Care, Utrecht, The Netherlands
Boris Vlaemynck
4SYNLAB, Heppignies, Belgium
Raf Schepers
4SYNLAB, Heppignies, Belgium
Arianne B. van Gageldonk-Lafeber
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Susan van den Hof
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Chantal B.E.M. Reusken
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Mirjam J. Knol
1Center for Infectious Disease Control, WHO COVID-19 reference laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

Article usage
Posted December 21, 2021.
Increased risk of infection with SARS-CoV-2 Omicron compared to Delta in vaccinated and previously infected individuals, the Netherlands, 22 November to 19 December 2021
Dirk Eggink, Stijn P. Andeweg, Harry Vennema, Noortje van Maarseveen, Klaas Vermaas, Boris Vlaemynck, Raf Schepers, Arianne B. van Gageldonk-Lafeber, Susan van den Hof, Chantal B.E.M. Reusken, Mirjam J. Knol
medRxiv 2021.12.20.21268121; doi: https://doi.org/10.1101/2021.12.20.21268121
Increased risk of infection with SARS-CoV-2 Omicron compared to Delta in vaccinated and previously infected individuals, the Netherlands, 22 November to 19 December 2021
Dirk Eggink, Stijn P. Andeweg, Harry Vennema, Noortje van Maarseveen, Klaas Vermaas, Boris Vlaemynck, Raf Schepers, Arianne B. van Gageldonk-Lafeber, Susan van den Hof, Chantal B.E.M. Reusken, Mirjam J. Knol
medRxiv 2021.12.20.21268121; doi: https://doi.org/10.1101/2021.12.20.21268121
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (213)
- Cardiovascular Medicine (3035)
- Dermatology (258)
- Emergency Medicine (454)
- Epidemiology (12953)
- Forensic Medicine (12)
- Gastroenterology (845)
- Genetic and Genomic Medicine (4760)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3023)
- Health Policy (1094)
- Hematology (405)
- HIV/AIDS (951)
- Medical Education (450)
- Medical Ethics (118)
- Nephrology (489)
- Neurology (4540)
- Nursing (242)
- Nutrition (671)
- Oncology (2356)
- Ophthalmology (665)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (85)
- Pathology (512)
- Pediatrics (1227)
- Primary Care Research (515)
- Public and Global Health (7123)
- Radiology and Imaging (1581)
- Respiratory Medicine (939)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (503)
- Toxicology (63)
- Transplantation (218)
- Urology (187)